Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Cardiology

  • 1
    News

    ENGAGE AF-TIMI: Insulin linked to greater risk for stroke, CV death, bleeding

    December 16, 2019

    LOS ANGELES – Use of novel oral anticoagulants may be preferred over vitamin K antagonists in patients with diabetes and AFib.

  • 1
    News

    New ASH guideline: VTE prophylaxis after major surgery

    December 12, 2019

    ORLANDO – The chair of VTE guidelines panel presented highlights of the latest guidelines in a special session at the annual meeting of the American Society of Hematology.

  • 1
    News

    Cardiac arrhythmia heightens mortality risk during epilepsy hospitalizations

    December 11, 2019

    BALTIMORE – A secondary diagnosis of apnea is not independently associated with increased odds of death, however.

  • 1
    News

    Genetic test stratified AFib patients with low CHA2DS2-VASc scores

    December 9, 2019

    A 32-locus genetic test classified AFib patients with low CHA2DS2-VASc scores into high– and low–stroke-risk subgroups.

  • 1
    News

    New heart failure trial data presage guideline revisions

    December 9, 2019

    PHILADELPHIA – Recent trial findings for sacubitril/valsartan and dapagliflozin in heart failure patients provide a blueprint for guideline changes.

  • 1
    News

    Aspirin plus a DOAC may do more harm than good in some

    December 8, 2019

    Adding aspirin to DOAC therapy for the secondary prevention of VTE or the prevention of stroke associated with NVAF without a clear indication increased bleeding risks in a large cohort.

  • 1
    News

    DAPA-HF: Dapagliflozin benefits regardless of age, HF severity

    November 25, 2019

    PHILADELPHIA – The SGLT2 inhibitor had similar efficacy in the elderly, and across the spectrum of baseline symptom status.

  • 1
    News

    Large population-based study underscores link between gout, CVD event risk

    November 23, 2019

    ATLANTA – The relationships between gout and fatal and nonfatal CVD events found in a large population-based health data linkage study in New Zealand were not ameliorated by allopurinol use or serum urate lowering to treatment target.

  • News

    Hyperkalemia-related treatment changes linked to death in acute HF

    November 21, 2019

    It’s not the potassium, but the subsequent dosage reduction, that may boost mortality after hospitalization for acute heart failure.

  • 1
    News

    Risk stratification of syncope patients can help determine duration of telemetry monitoring

    November 12, 2019

    In ED patients with syncope, what is the optimal duration of telemetry monitoring to detect underlying arrhythmia?

Previous1 … 39 40 41 42 43 … 79Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences